Smith & Nephew's CFO Transition
Smith & Nephew CFO John Rogers Steps Down; Pierre Palassian Appointed Interim, Shares Rise
Key Points
Palassian’s scope of responsibility extends beyond general finance duties to oversee Global Operations, R&D, Advanced Wound Management, Sports Medicine, International Markets and Emerging Markets, ensuring continuity across multiple core units during the transition.
Pierre Palassian joined Smith+Nephew in June 2017 and has previously held senior roles at AbbVie and Abbott Laboratories, bringing more than two decades of finance leadership to the interim CFO role.
The CFO transition was announced after Smith+Nephew reported its first-half results, framing the leadership change in the context of recent financial performance and period results.
Smith+Nephew’s stock moved higher on the news, with the London-listed shares closing about 2.07% up on the trading day of the announcement.
Smith & Nephew CFO John Rogers is leaving the company on September 30 to take a new role in the United States, and will step down from the board immediately, according to MarketScreener. The medical device maker has launched a search for a permanent replacement.
Pierre Palassian, the company's Senior Vice President of Finance and Group Controller, will serve as interim CFO during the search, according to LSE. Smith & Nephew's London-listed shares closed about 2.07% higher on the day of the announcement.
Rogers Exits After Just Over Two Years as CFO
Rogers became CFO in April 2024, giving him a tenure of just over two years, according to LSE. CEO Deepak Nath thanked him for his contributions, saying Rogers helped deliver the company's 12-Point Plan and played a key role in shaping the RISE strategy. The 12-Point Plan was a structured turnaround program the company had been working through in recent years.
The departure was announced alongside Smith & Nephew's first-half financial results, framing the leadership change in the context of recent performance, according to MarketScreener. Rogers will resign from the board right away, even though his last day in the CFO role is September 30.
Palassian Steps Up With a Wide Remit
Pierre Palassian joined Smith & Nephew in June 2017 and brings more than two decades of finance leadership to the interim role, according to TipRanks. He previously held senior positions at AbbVie and Abbott Laboratories. His appointment is designed to keep the business stable while the permanent search runs.
Palassian's responsibilities go well beyond standard finance duties. He will oversee Global Operations, R&D, Advanced Wound Management, Sports Medicine, International Markets, and Emerging Markets during the transition. That broad scope is meant to ensure no major unit loses direction while the company looks for Rogers's successor.
Stock Rises as Market Digests Leadership News
Smith & Nephew's London-listed shares closed up about 2.07% on the day of the announcement, according to LSE. The gain suggests investors took the CFO change and the interim appointment in stride. The move came on the same day the company reported its first-half results, which may also have supported the share price.
Search Underway for a Permanent Finance Chief
Smith & Nephew has started a formal search for a new CFO, according to MarketScreener. The company did not say how long the process would take or whether it would look inside or outside the company. Palassian will hold the interim role until a permanent successor is named and in place.
The company stressed continuity as its top priority during the transition. With Palassian overseeing multiple core units, Smith & Nephew is signaling it does not expect a gap in financial or operational leadership during the handover period.
Sentiment
Mostly NegativePublishers
13
Articles
89
Reach
102
